2,266 followers
Retrospective study in Italy of 961 patients (Feb–Jun 2022). Early oral antivirals for mild/moderate COVID-19 during Omicron era cost more than no treatment, driven by high drug prices. eurjmedres.biomedcentral.com/articles/10....
Impact of oral early antiviral therapies for mild–moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis
Overview of attention for article published in European Journal of Medical Research, December 2024
Altmetric Badge
Readers on
- mendeley
- 3 Mendeley